These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 24325612)
41. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test. Printz C Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486 [No Abstract] [Full Text] [Related]
42. Papanicolaou smears and risk of cervical neoplasia. Lancet; 1984 Nov; 2(8411):1099-100. PubMed ID: 6150171 [No Abstract] [Full Text] [Related]
44. Carcinoma of the uterine cervix and utilization of the Papanicolaou smear technique. Lee RE Proc Inst Med Chic; 1979; 32(7):142-4, 153. PubMed ID: 392500 [No Abstract] [Full Text] [Related]
45. Follow-up of unsatisfactory Papanicolaou test results. McGaraghan A; Smith-McCune K JAMA; 2000 Mar; 283(10):1290-1. PubMed ID: 10714724 [No Abstract] [Full Text] [Related]
46. ASCCP patient management guidelines: Pap test specimen adequacy and quality indicators. Davey DD; Austin RM; Birdsong G; Buck HW; Cox JT; Darragh TM; Elgert PA; Hanson V; Henry MR; Waldman J; Am J Clin Pathol; 2002 Nov; 118(5):714-8. PubMed ID: 12428791 [TBL] [Abstract][Full Text] [Related]
47. Should U.S. women be screened for cervical cancer with pap tests, HPV tests, or both? Perkins RB; Stier EA Ann Intern Med; 2014 Aug; 161(4):295-7. PubMed ID: 24912666 [No Abstract] [Full Text] [Related]
48. The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan. Chang JI; Ou CH; Wu KM; Chen CC; Cheng KC Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):430-4. PubMed ID: 12433029 [TBL] [Abstract][Full Text] [Related]
49. Development of a Pap smear quality-assurance system in family practice. Curtis P; Varenholt JJ; Skinner B; Addison L; Resnick J; Kebede M Fam Med; 1993 Feb; 25(2):135-9. PubMed ID: 8458544 [TBL] [Abstract][Full Text] [Related]
50. American College of Obstetricians and Gynecologists releases new guidelines for Papanicolaou (Pap) tests. Sperling R Home Healthc Nurse; 2004 Mar; 22(3):163. PubMed ID: 15017317 [No Abstract] [Full Text] [Related]
51. The clinical significance of class III cervical Pap smear. SMITH CW; SEALEY RM Am Surg; 1962 Jul; 28():420-2. PubMed ID: 13914180 [No Abstract] [Full Text] [Related]
52. Rescreening of cervical Papanicolaou smears using PAPNET. Koss LG JAMA; 1998 Jun; 279(22):1786; author reply 1787-8. PubMed ID: 9628706 [No Abstract] [Full Text] [Related]
53. [What to do after an abnormal pap smear test result?]. Gondry J; Muszynski C; Chevreau J Rev Prat; 2014 Jun; 64(6):786-8. PubMed ID: 25090761 [No Abstract] [Full Text] [Related]
54. Benefits of the conventional Papanicolaou smear. Mali BN; Hazari KT; Joshi JV Acta Cytol; 2004; 48(3):466-7. PubMed ID: 15192976 [No Abstract] [Full Text] [Related]
55. Clinical evaluation of the Pap smear and the importance of followup. Lash AF IMJ Ill Med J; 1969 Apr; 135(4):408-11 passim. PubMed ID: 4388495 [No Abstract] [Full Text] [Related]
56. The Papanicolaou smear histories of 237 patients with cervical cancer. Grace J Med J Aust; 1992 Sep; 157(5):353. PubMed ID: 1435485 [No Abstract] [Full Text] [Related]
57. Annual colposcopies and pap smears recommended for women with HIV. Highleyman L BETA; 1999 Apr; 12(2):6. PubMed ID: 11366700 [TBL] [Abstract][Full Text] [Related]
58. Pap smear preceptor program. Harris-Bray S Aust Nurs Midwifery J; 2014 Apr; 21(9):42. PubMed ID: 24812782 [No Abstract] [Full Text] [Related]
60. Validation of the Modification of the Prolonged Papanicolaou Stain for the Diagnosis of Cervical Cancer. Moya-Salazar J; Rojas-Zumaran V Acta Cytol; 2016; 60(1):79-84. PubMed ID: 26942573 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]